Liposcale for early and reliable diagnosis and prognosis of breast cancer patients
One of the key features of malignant tumour cells is that their energy metabolism is altered. However, in recent years, alterations in lipid metabolism have been described in some types of cancer. A study led by the team of Dr. Josep Gumà and Dr. Sandra Guaita from the Pere Virgili Health Research Institute (IISPV) and […]
Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test
Patients with chronic kidney disease (CKD) have a high burden of atheromatous cardiovascular disease (ASCVD) that is not fully explained by traditional lipid parameters. A study published in the clinical Kidney journal, conducted in patients with chronic kidney disease, reveals that information on lipoprotein composition and subclass particle number using the Liposcale test could improve […]
Biosfer Co-Leads a project to implement the first in vitro prognostic test for covid-19.
The Agency for the Management of University and Research Grants (AGAUR) has awarded the grant for the funding of research projects PANDÈMIES 2020 to the MiL@b research group of the IISPV, the URV and the spin-off Biosfer Teslab, SL. The call granted has been “Replegar-se per crèixer: l’impacte de les pandèmies en un món sense […]
Biosfer Teslab participates in a video of covid-19 research
Last week, in Biosfer Teslab, we participated in the video made as part of the URVGoals project, which shows different research being carried out at the URV with a common goal: to fight against the pandemic. The video shows eight research projects from all fields showing that the fight against covid-19 is totally transversal. In […]
Biosfer Teslab Collaborates in Cancer Studies
Metabolomics can help in the study of different cancers by analysing whether a particular type of tumour is characterised by the development of certain metabolites. To this aim, Biosfer Teslab collaborates directly with Josep Gumà, director of the Oncology Institute of Southern Catalonia, and together with the Higher Technical School of Engineering of the URV […]
Nuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsia
Dr. Amor and collaborators have published a new article in the Diabetes Research and Clinical Practice journal using our plasma metabolomics analysis. The aim of the study was to evaluate the role of plasma metabolomics in atherosclerosis according to the presence of type 1 diabetes (T1D) or previous preeclampsia. They have concluded that plasma metabolomics […]
